White cell toxicity: A predictive marker for survival after adjuvant and neoadjuvant chemotherapy for breast cancer?

被引:0
|
作者
Pandha, HS [1 ]
Ashley, S [1 ]
Smith, IE [1 ]
机构
[1] Royal Marsden Hosp, Dept Med, Sutton SM2 5PT, Surrey, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
26
引用
收藏
页码:12 / 12
页数:1
相关论文
共 50 条
  • [31] Toxicity in elderly breast cancer patients treated by a taxane based chemotherapy as adjuvant or neoadjuvant therapy for primary breast cancer
    Loibl, S.
    von Minckwitz, G.
    Elling, D.
    Janni, W.
    Kaufmann, M.
    Vescia, S.
    Eggemann, H.
    Harbeck, N.
    Nekljudova, V.
    Kuemmel, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 158 - 158
  • [32] Predictive factors associated with invasive lobular breast cancer after neoadjuvant chemotherapy
    Julian, T. B.
    Anderson, S.
    Fourchotte, V.
    Zieger, S.
    Mamounas, E.
    Bear, H.
    Costantino, J.
    Wolmark, N.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 17 - 17
  • [33] The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer
    Pieper, Willi
    Ignatov, Atanas
    Kalinski, Thomas
    Haybaeck, Johannes
    Czapiewski, Piotr
    Nass, Norbert
    CANCER BIOMARKERS, 2021, 32 (02) : 161 - 173
  • [34] Predictive markers of response to neoadjuvant chemotherapy in breast cancer
    Tewari, Mallika
    Krishnamurthy, Arvind
    Shukla, Hari S.
    SURGICAL ONCOLOGY-OXFORD, 2008, 17 (04): : 301 - 311
  • [35] Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
    Fuksa, L.
    Micuda, S.
    Grim, J.
    Ryska, A.
    Hornychova, H.
    CANCER INVESTIGATION, 2012, 30 (09) : 663 - 678
  • [36] Adjuvant Chemotherapy after neoadjuvant Chemoradiotherapy for Rectal cancer
    Reibetanz, J.
    Germer, C. -T.
    CHIRURG, 2014, 85 (06): : 544 - 544
  • [37] A pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer
    Mayer, E. L.
    Miller, K. D.
    Rugo, H. S.
    Peppercorn, J. M.
    Carey, L. A.
    Ryabin, N.
    Josephs, K.
    Winer, E. P.
    Burstein, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Concurrent Chemotherapy With Adjuvant Radiation for Breast Cancer After Incomplete Response to Neoadjuvant Chemotherapy: Safety and Outcomes
    Mullen, Thomas D.
    Chang, Amy E.
    Linden, Hannah M.
    Kim, Janice N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E18 - E18
  • [39] Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
    Symmans, W. Fraser
    Peintinger, Florentia
    Hatzis, Christos
    Rajan, Radhika
    Kuerer, Henry
    Valero, Vicente
    Assad, Lina
    Poniecka, Anna
    Hennessy, Bryan
    Green, Marjorie
    Buzdar, Aman U.
    Singletary, S. Eva
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4414 - 4422
  • [40] Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes
    Mahmoud Al-Masri
    Basim Aljalabneh
    Hani Al-Najjar
    Tamador Al-Shamaileh
    Breast Cancer Research and Treatment, 2021, 186 : 7 - 13